Below are our currently enrolling studies for patients with sjogren's.
Sponsor: Novartis
/assets/production/practices/c1f0c98a14a26efc3f61c530443c39569f27073b/images/2693136.jpg)
Sponsor: NovartisProtocol Number: CVAY736A2302
A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjögren's syndrome (NEPTUNUS-2)
Detailed Information: Here
To learn more or see if you qualify: Click Here
/assets/docs/421578.png)
Sponsor: Bristol-Myers Squibb
Protocol Number: IM011-1069
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Detailed Information: Here
To learn more or see if you qualify: Click Here